Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2002Journal of Clinical Oncology

Generation of T-Cell Immunity to the HER-2/neu Protein After Active Immunization With HER-2/neu Peptide–Based Vaccines

View Full Paper
Ask AI
Bookmark
Share

Authors

MDMary L. DisisUniversity of WashingtonTGTheodore A. GooleyFred Hutch Cancer CenterKRKristine RinnCancer Care Northwest

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Disis et al. (2002) studied this question.

synapsesocial.com/papers/69dd2e7c7808b00a4799b65fhttps://doi.org/10.1200/jco.2002.06.171
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mapping the major human T helper epitopes of tetanus toxin. The emerging picture.1993 · 106 citations
  2. 2Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing.1992 · 268 citations
  3. 3Tolerance to a self-protein involves its immunodominant but does not involve its subdominant determinants.1992 · 222 citations
  4. 4Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu Oncogene1985 · 1,825 citations